Upexi Inc.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its pr… Read more
Upexi Inc. (UPXI) - Total Liabilities
Latest total liabilities as of December 2025: $222.43 Million USD
Based on the latest financial reports, Upexi Inc. (UPXI) has total liabilities worth $222.43 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Upexi Inc. - Total Liabilities Trend (2019–2025)
This chart illustrates how Upexi Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Upexi Inc. Competitors by Total Liabilities
The table below lists competitors of Upexi Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Saint Jean Groupe Société anonyme
PA:SABE
|
France | €94.56 Million |
|
Prime Securities Limited
NSE:PRIMESECU
|
India | ₹291.90 Million |
|
UY Scuti Acquisition Corp.
NASDAQ:UYSC
|
USA | $58.23 Million |
|
PT Sinergi Inti Andalan Prima Tbk
JK:INET
|
Indonesia | Rp93.09 Billion |
|
Rhoen Klinikum AG
IL:0NQH
|
UK | €530.90 Million |
|
CTCBIO Inc
KQ:060590
|
Korea | ₩77.43 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Upexi Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Upexi Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Upexi Inc. (2019–2025)
The table below shows the annual total liabilities of Upexi Inc. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $33.71 Million | +98.35% |
| 2024-06-30 | $17.00 Million | -52.75% |
| 2023-06-30 | $35.96 Million | +82.52% |
| 2022-06-30 | $19.70 Million | +226.41% |
| 2021-06-30 | $6.04 Million | +42.95% |
| 2020-06-30 | $4.22 Million | +281.27% |
| 2019-06-30 | $1.11 Million | -- |